Lubris LLC

Rhode Island Hospital

Other

Rhode Island Hospital, a Lifespan-partner

Gregory D Jay

Tannin A Schmidt

Benjamin D Sullivan

Tannin Avery Schmidt

Jawed Fareed

Roman Krawetz

Khaled Elsaid

Edward R Truitt, Iii

Edward R Truitt

Adam Chodobski

Joanna Szmydynger-Chodobska

Selim Suner

Kevin S Ernsting

Benjamin Sullivan

Tannin Schmidt

Disclosed are new recombinant isoforms of human-like lubricin or PRG4 glycoprotein having outstanding lubrication properties and a novel glycosylation pattern, and methods for their manufacture at high levels enabling commercial production.

Production of recombinant lubricin

Disclosed are compositions and methods involving the use of PRG4 protein, also known as lubricin, to mechanically inhibit biological processes involving cell motility and adhesion. The methods and compositions may be used to develop a variety of specific therapies and compositions, often exploited through surgical procedures, where development of the pathology involves one or more of the following modes of action: 1) the passage of cells from one body compartment to another, 2) adherence of macrophages to substrates such as fibrin or exposed extra cellular matrix, 3) binding of platelets to fibrin, or 4) failure of function of the glycocalyx on exposed epithelial cell surfaces, e.g., within the vasculature. In these instances PRG4 glycoprotein adheres to extracellular matrix or cell surfaces and presents a glycol-surface of polysaccharide which blocks the mechanisms of cell motility, extravasation, or intravasation, inhibits sticking of macrophages and platelets, and/or serves as a substitute or mimic of native glycocalyx.

Compositions and methods for inhibiting intercellular interactions

Disclosed herein are methods of using PRG4 glycoprotein, also known as lubricin, to reduce, inhibit, or down-regulate pro-inflammatory pathways in patients at risk of or suffering from an inflammatory response or allergy symptom through CD44 antagonization, regulating pro-inflammatory cytokine production, inhibiting NF-&#x3ba;B translocation and/or facilitating removal of inflammation-inducing cellular or matrix debris or allergens.

Use of PRG4 as an anti-inflammatory agent

Recombinant lubricin

Disclosed are compositions and methods involving the use of PRG4 protein, also known as lubricin, to mechanically inhibit biological processes involving cell motility and adhesion. The methods and compositions may be used to develop a variety of specific therapies and compositions, often exploited through surgical procedures, where development of the pathology involves one or more of the following modes of action: 1) the passage of cells from one body compartment to another, 2) adherence of macrophages to substrates such as fibrin or exposed extra cellular matrix, 3) binding of platelets to fibrin, or 4) failure of function of the glycocalyx on exposed epithelial cell surfaces, e.g., within the vasculature. In these instances PRG4 glycoprotein adheres to extracellular matrix or cell surfaces and presents a glycol-surface of polysaccharide which blocks the mechanisms of cell motility, extravasation, or intravazation, inhibits sticking of macrophages and platelets, and/or serves as a substitute or mimic of native glycocalyx.

Recombinant lubricin composition

The invention features a tribonectin and a method of tribosupplementation carried out by administering tribonectins directly to an injured or arthritic joint.

Tribonectins

A method of estimating an amount of a substance in a bodily fluid from the color of a tissue surface of a subject includes capturing an image including at least a portion-of-interest of the subject and at least a reference portion of a color reference, the image being a digital image of pixels of at least one color, the image including a component value for each pixel for each of the at least one color, obtaining a first value associated with at least one component value corresponding to the portion-of-interest of the subject, obtaining a second value associated with at least one component value corresponding to the reference portion, and calculating an estimated amount of the substance using the first and second values.

Non-invasive determination of blood components

Treating degenerative joint disorders with tribonectins

A system for determining an indication of animal joint mobility includes a mounting apparatus configured to hold a first condyle of the joint stationary in a position such that a second condyle of the joint can pivot about the joint, a pendulum configured to be coupled to the second condyle and configured such that a portion of a weight of the pendulum is disposed below a pivot axis of the joint such that the pendulum and second condyle can oscillate about the pivot axis, an angular displacement indicator associated with the pendulum, an angular displacement recorder configured to store indicia of the angular displacement, as indicated by the angular displacement indicator; of the pendulum over time, and a processor coupled to the angular displacement recorder and configured to use the angular displacement indicia to determine a first value associated with momentum decay of oscillations of the pendulum and to use the at least one value to determine a second value associated with a coefficient of friction of the joint.

Joint friction sensing

Growing community of inventors

Norfolk, MA, United States of America

Gregory D Jay